Literature DB >> 7696733

Vancomycin serum concentration monitoring: a continued debate.

R D Pryka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7696733     DOI： 10.1177/106002809402801212

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN： 1060-0280            Impact factor:   3.154


× No keyword cloud information.
  5 in total

1.  Population pharmacokinetic analysis of vancomycin in neonates. A new proposal of initial dosage guideline.

Authors:  María-Remedios Marqués-Miñana; Anas Saadeddin; José-Esteban Peris
Journal:  Br J Clin Pharmacol       Date:  2010-11       Impact factor: 4.335

Review 2.  Pharmacokinetics and administration regimens of vancomycin in neonates, infants and children.

Authors:  K A Rodvold; J A Everett; R D Pryka; D M Kraus
Journal:  Clin Pharmacokinet       Date:  1997-07       Impact factor: 6.447

Review 3.  Does oral vancomycin use necessitate therapeutic drug monitoring?

Authors:  Nevio Cimolai
Journal:  Infection       Date:  2019-11-11       Impact factor: 3.553

4.  Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections.

Authors:  J K James; S M Palmer; D P Levine; M J Rybak
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

Review 5.  Benefits of therapeutic drug monitoring of vancomycin: a systematic review and meta-analysis.

Authors:  Zhi-Kang Ye; Hui-Lin Tang; Suo-Di Zhai
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.